PML-RARA NORMALIZED COPY NUMBER AFTER CONSOLIDATION THERAPY CAN STRATIFY THE RISK OF RELAPSE IN ADULT EGYPTIAN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA

PML-RARA NORMALIZED COPY NUMBER AFTER CONSOLIDATION THERAPY CAN STRATIFY THE RISK OF RELAPSE IN ADULT EGYPTIAN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA

Background and objectives: PML-RARA quantification by real time polymerase chain reaction (RQ-PCR) is an important tool for detecting minimal residual disease (MRD) in patients with acute promyelocytic leukemia (APL). We aimed to analyze the association between risk of relapse in APL patients and re...

Full description

Saved in:

Bibliographic Details
Main Author:	yasser hassan elnahass
Format:	Article
Language:	English
Published:	PAGEPress Publications 2014-08-01
Series:	Mediterranean Journal of Hematology and Infectious Diseases
Online Access:	https://mjhid.org/index.php/mjhid/article/view/1744
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Detection of cytogenetically cryptic PML-RARA fusion in acute promyelocytic leukemia by rapid next generation sequencing
by: Hailee St. Louis, et al.
Published: (2025-08-01)

HIF factors cooperate with PML‐RARα to promote acute promyelocytic leukemia progression and relapse
by: Nadia Coltella, et al.
Published: (2014-04-01)

Rapid Detection of <i>PML::RARA</i> Fusions in Acute Promyelocytic Leukemia: CRISPR/Cas9 Nanopore Sequencing with Adaptive Sampling
by: William Middlezong, et al.
Published: (2024-12-01)

Isochromosome der(17)(q10)t(15;17) in acute promyelocytic leukemia resulting in an additional copy of the RARA-PML and loss of one p53 gene: Report of two cases and literature review
by: Đorđević Vesna, et al.
Published: (2019-01-01)

Effects of arsenic on the topology and solubility of promyelocytic leukemia (PML)-nuclear bodies.
by: Seishiro Hirano, et al.
Published: (2022-01-01)

Mutation in the Unrearranged PML Allele Confers Resistance to Arsenic Trioxide in Acute Promyelocytic Leukemia
by: Pei-Han Yu, et al.
Published: (2025-01-01)

Acute promyelocytic leukemia relapsing into acute myeloid leukemia-M2 with normal cytogenetics
by: Ranjit Kumar Sahoo, et al.
Published: (2013-01-01)

Cardiac Glycosides Activate the Tumor Suppressor and Viral Restriction Factor Promyelocytic Leukemia Protein (PML).
by: Snezana Milutinovic, et al.
Published: (2016-01-01)

Acute promyelocytic leukemia lacking t(15;17): Molecular evidence of atypical PML/RAR-α transcriptional variant by gene sequencing
by: Đorđević Vesna, et al.
Published: (2020-01-01)

Venetoclax for an ATRA and ATO resistance acute promyelocytic leukemia patient with TNRC18::RARA fusion gene
by: Weina Li, et al.
Published: (2024-01-01)

The interaction between herpes simplex virus 1 genome and promyelocytic leukemia nuclear bodies (PML-NBs) as a hallmark of the entry in latency
by: Patrick Lomonte
Published: (2016-11-01)

Central Nervous System Double Relapse of Acute Promyelocytic Leukemia and Acute Myelomonocytic Leukemia
by: Laura M. Stanko, et al.
Published: (2019-01-01)

Pattern of Expression of PML-RARα Transcripts in Acute Promyelocytic Leukemia Patients and Its Correlation with Overall Survival: A Retrospective Study from Western India
by: Shweta Gondha, et al.
Published: (2025-06-01)

Acute promyelocytic leukemia with <i>TTMV::RARA</i> fusion potentially responds to all-trans retinoic acid/arsenic trioxide treatment
by: Qingyu Xu, et al.
Published: (2025-01-01)

Atypical acute promyelocytic leukemia with tripartite fusion gene <i>PML::RARG::LINE-L2a</i> is resistant to ATRA but sensitive to arsenic-based therapy
by: Sanyun Wu, et al.
Published: (2025-06-01)

Combination of arsenicum trioxide and all trans retinoic acid in the treatment of relapsed acute promyelocytic leukemia
by: A. N. Sokolov, et al.
Published: (2015-06-01)

DISTRIBUTION OF DIFFERENT PML/RARΑ BCR ISOFORMS IN INDIAN ACUTE PROMYELOCYTIC LEUKAEMIA (APL) PATIENTS AND CLINICOHEMATOLOGICAL CORRELATION
by: Tathagata Chatterjee, et al.
Published: (2013-12-01)

Venetoclax plus arsenic and all-trans retinoic acid in patients with relapsed/refractory acute promyelocytic leukemia
by: Bingqian Jiang, et al.
Published: (2025-07-01)

Effective treatment with Gilteritinib-based regimens for FLT3-mutant extramedullary relapse in acute promyelocytic leukemia
by: Chun-xiao Hou, et al.
Published: (2024-12-01)

Copy number normalization distinguishes differential signals driven by copy number differences in ATAC-seq and ChIP-seq
by: Dingwen Su, et al.
Published: (2025-03-01)

MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY
by: Francesco Lococo, et al.
Published: (2013-06-01)

Comparison of newly diagnosed and relapsed patients with acute promyelocytic leukemia treated with arsenic trioxide: insight into mechanisms of resistance.
by: Ezhilarasi Chendamarai, et al.
Published: (2015-01-01)

MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
by: Melanie Joannides, et al.
Published: (2011-10-01)

Basophils in Acute Promyelocytic Leukemia: Clonality or Reactiveness?
by: Xue Li, et al.
Published: (2025-06-01)

The boundaries between PML and PML-IRIS: difficult to define, pathology may predict
by: Jiamin Chen, et al.
Published: (2025-06-01)

A phase II study evaluating the role of bortezomib in the management of relapsed acute promyelocytic leukemia treated upfront with arsenic trioxide
by: Uday Kulkarni, et al.
Published: (2020-04-01)

Successful Control of Disseminated Intravascular Coagulation by Recombinant Thrombomodulin during Arsenic Trioxide Treatment in Relapsed Patient with Acute Promyelocytic Leukemia
by: Motohiro Shindo, et al.
Published: (2012-01-01)

Mutational spectrum of BRCA genes in Egyptian patients with breast cancer
by: Wafaa Elmetnawy, et al.
Published: (2025-07-01)

Acute Promyelocytic Leukemia Presenting with Severe Marrow Fibrosis
by: Harsh Shah, et al.
Published: (2015-01-01)

Deluging thrombosis: An unusual presentation of acute promyelocytic leukemia
by: Aditya Jandial, et al.
Published: (2020-01-01)

EPIDEMIOLOGY AND TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN LATIN AMERICA
by: Rafael Henriques Jácomo, et al.
Published: (2011-01-01)

PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
by: Laura Russo, et al.
Published: (2011-01-01)

TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH AIDA BASED REGIMEN
by: Hela Ben Abid, et al.
Published: (2011-01-01)

EPIDEMIOLOGY AND TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN LATIN AMERICA
by: Eduardo Magalhães Rego, et al.
Published: (2011-10-01)

Characterization and functional analysis of chicken promyelocytic leukemia protein
by: Shengnan Wang, et al.
Published: (2024-12-01)

Treatment of a Patient with Acute Promyelocytic Leukemia with Multiple Isolated Relapses in the Central Nervous System: A Case Report and Mini-Review of the Literature
by: Qixin Sun, et al.
Published: (2024-01-01)

Treatment Outcome of Acute Promyelocytic Leukemia with Modified Aida Protocol
by: Kátia B. Barbosa Pagnano, et al.
Published: (2010-01-01)

HISTORY OF ACUTE PROMYELOCYTIC LEUKEMIA: A TALE OF ENDLESS REVOLUTION
by: Laura Cicconi, et al.
Published: (2011-01-01)

DIFFERENTIATION SYNDROME IN PROMYELOCYTIC LEUKEMIA : CLINICAL PRESENTATION, PATHOGENESIS AND TREATMENT
by: Gil Cunha de Santis, et al.
Published: (2011-01-01)

HISTORY OF ACUTE PROMYELOCYTIC LEUKEMIA: A TALE OF ENDLESS REVOLUTION
by: Francesco Lo-Coco, et al.
Published: (2011-12-01)